معرفی
Henrik Grönberg is a Professor of Cancer Epidemiology at Karolinska Institutet and Head of the Capio S:t Göran Hospital Prostate Cancer Center in Stockholm. He leads the Department of Medical Epidemiology and Biostatistics, focusing on prostate cancer genetics, risk prediction, and precision diagnostics. His research includes developing the Stockholm3 blood test for aggressive prostate cancer detection and the ProBio trial evaluating treatment biomarkers. He has held leadership roles, including Acting Pro-Vice-Chancellor at Karolinska Institutet and Chairman of the Department of Medical Epidemiology and Biostatistics (2008–2013).
- Key Projects: STHLM3 trial, ProBio platform trial, and MRI-guided biopsy strategies.
- Grants: Swedish Cancer Society, Swedish Research Council, VINNOVA-funded initiatives.
- Students: Supervises Andreas Karlsson on prostate cancer screening modeling.
Research interests span prostate cancer genetics, biomarker development, and clinical trial design. His work aims to improve early detection and personalized treatment, reducing overdiagnosis and optimizing patient outcomes.
